Future of IVD Contract Manufacturing Services Market
Meticulous Research®—a leading market research company, published a research report titled, 'IVD Contract Manufacturing Services Market by Type (Assay Development, Manufacturing), Category (Reagents, Systems), Technology (Immunoassay, Molecular Diagnostics, Clinical Chemistry, Hematology, Microbiology, Urinalysis) – Global Forecast to 2031’
According to this latest publication
from Meticulous Research®, the IVD contract manufacturing services
market is projected to reach $25.75 billion by 2031, at a CAGR of 7.8%
from 2024 to 2031. The growth of the IVD contract manufacturing services market
is driven by several factors, including the rising prevalence of infectious
diseases, the shift in focus from centralized laboratories to point-of-care
testing services, regulatory complexities faced by IVD companies, and the need
for cost-effective manufacturing of IVD tests. Factors such as high economic growth
and increased outsourcing to emerging countries serve as an opportunity that
would help grow the market in the future.
Factors such as the lack of skilled
professionals could be considered as a challenge for the IVD contract
manufacturing services market. However, maintaining product quality and
protection of proprietary information restrains the growth of the market.
Key Players
The key players profiled in the IVD
contract manufacturing services market report are Cenogenics Corporation
(U.S.), In-Vitro Diagnostic Developers, Inc. (IDxDI) (U.S.), Savyon Diagnostics
(Israel), KMS Systems, Inc. (U.S.), Nova Biomedical (U.S.), LRE Medical
(Germany), Cone Bioproducts (U.S.), Invetech, Inc. (Australia), Avioq, Inc.
(U.S.), TCS Biosciences Ltd. (U.K.), Affinity Life Sciences, Inc. (U.S.), Coris
BioConcept (Belgium), Meridian Bioscience, Inc. (U.S.), Affinity Biologicals,
Inc. (Canada), Biokit S.A. (Spain), Merck KgaA (Germany), Thermo Fisher
Scientific, Inc. (U.S.), and Maxim Biomedical, Inc. (U.S.).
The IVD contract manufacturing
services market is segmented by Type (Assay Development Services, Manufacturing
Services, and Other Services), Category (Reagents & Consumables and
Instruments & Systems), Technology (Immunoassay, Molecular Diagnostics,
Clinical Chemistry, Hematology, Microbiology, and Urinalysis), and Geography.
The study also evaluates industry competitors and analyzes the regional and
country-level markets.
Based on type, in 2024, the manufacturing services
segment is expected to account for the largest share of the market.
Manufacturing services are services that include ISO-certified manufacturing
facilities that allow them to carry out full project and production management,
quality and regulatory support, and flexibility in scale and process, which
results in increased demand for manufacturing services.
Based on category, in 2024, the reagents & consumables
segment is expected to account for the largest share of the market.
Reagents & consumables are products that are used for the in-vitro
examination of specimens derived from the human body during disease diagnosis,
treatment monitoring, prognosis, and evaluation of the patient’s health status.
The large market share of the segment is attributed to factors such as
increasing virulence of infectious diseases, growth of companion diagnostics,
and rapid growth in molecular testing, which leads to an increased demand for
POC diagnostic kits, therefore increasing the use of reagents & consumables
used in the tests.
Based on technology, in 2024, the immunoassay segment is expected
to account for the largest share of the market. The large share of the segment
is attributed to factors such as a higher preference for immunodiagnostics
owing to its inherent specificity, high throughput, and the emergence of
advanced diagnostic immunoassay formats. Further, the increasing use of
immunoassays in Point of Care (PoC) infectious disease testing, the need for
developing novel tests, increasing usage of miniaturized devices, rising demand
attributed to an aging population, and the rising trend of automation in
immunoassay instruments are driving the growth of this segment.
This research report analyzes major
geographies and provides a comprehensive analysis of North America (U.S.,
Canada), Europe (Germany, France, U.K., Italy, Spain, and the Rest of Europe),
Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), Latin America and
the Middle East & Africa. In 2024, North America is expected to account for
the largest share of the IVD contract manufacturing services market, followed
by Europe and Asia-Pacific. North America’s major market share is attributed to
the rising prevalence of various infectious diseases, the growing healthcare
sector, increasing awareness regarding early disease diagnosis, growing
adoption of advanced innovative products, and increasing funding activities
coupled with novel advanced diagnostic technologies.
Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5226
Key questions answered in the
report:
·
Which are
the high-growth market segments in terms of IVD contract manufacturing services
type, category, technology, and geography?
·
What was
the historical market for IVD contract manufacturing services across the globe?
·
What are
the market forecasts and estimates for the period 2024–2031?
·
What are
the major drivers, restraints, opportunities, and challenges in the IVD
contract manufacturing services market?
·
Who are
the major players in the IVD contract manufacturing services market?
·
What is
the competitive landscape, and who are the market leaders in the IVD contract
manufacturing services market?
·
What are
the recent developments in the global IVD contract manufacturing services
market?
·
What are
the different strategies adopted by the major players in the global IVD
contract manufacturing services market?
·
What are
the geographical trends and high-growth regions/countries?
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Comments
Post a Comment